VADUZ, Liechtenstein, 27 Oct 2019, bonyf’s CSO, Dr Bart De Wever initiated two new clinical studies to evaluate the efficacy of PerioTabs® in patients wearing fixed orthodontic braces suffering from severe gingivitis.
Author: bonyf
Post
Evidence that OlivaFix® Gold Denture Adhesive Cream reduces growth of Candida albicans presented at the 2019 World Congress in Barcelona, Spain
BARCELONA, Spain, 10 Oct 2019 – The Complutense University of Madrid in Spain recently completed a clinical trial evaluating OlivaFix® Gold Denture Adhesive Cream (OlivaFix® Gold) and a leading denture fixative cream brand with 40 denture wearers from both Spain and Portugal.
Post
Superior results for OlivaFix® Gold Denture Adhesive Cream in large multi-centre clinical trial
VADUZ, Liechtenstein, 21 August 2019 - OlivaFix® Gold, an organic olive oil-based denture adhesive cream, free of mineral oil, Vaseline and zinc was recently evaluated in a clinical trial...
Post
Mr Timothy Foubert appointed as Chief Financial Officer
VADUZ, Liechtenstein, 1 Aug 2019 – In a move to strengthen the company's management team, Mr Timothy Foubert was recently appointed as the Chief Financial Officer of bonyf AG.
Post
bonyf’s latest innovative product PerioTabs® – described as a “miracle product”
BELGIUM, 20 June 2019 - The leading Belgian newspaper “Het Nieuwsblad” recently published an article on PerioTabs®, bonyf’s innovative product that helps reduce gum disease...
Post
CSO for bonyf presents PerioTabs® at the 2019 “DENTis” International Congress of Dental Medicine for Students and Young Dentists conference in Romania
CLUJ-NAPOCA, Romania, 21 March 2019 - Dr Bart De Wever, CSO of bonyf presented a lecture on PerioTabs®...